Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00781534 · ClinicalTrials.gov registry record · Early Phase 1
A Clinical Trial of Ginseng in Diabetes
A Early Phase 1 study, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 19
- Enrollment target
NCT00781534 is a Early Phase 1 study that has completed, run by Washington University School of Medicine. The registered enrollment target is 19 participants.
The verdict
NCT00781534, a Early Phase 1 study, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 19 participants
- Enrollment target
Study Summary
a clinical study of Ginseng its potential affect on diabetes
Interventions
- DRUG Ginseng
- DRUG ginsenoside RE
- DIETARY_SUPPLEMENT Placebo (sugar pill)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2003-09 |
| Est. Completion | 2008-09 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00781534
The ClinicalTrials.gov registry entry for NCT00781534 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Ginseng is the first listed.
NCT00781534 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00781534 about?
NCT00781534 is a clinical study titled "A Clinical Trial of Ginseng in Diabetes". a clinical study of Ginseng its potential affect on diabetes
What is the current status of trial NCT00781534?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 19 participants. The study started on 2003-09. Estimated completion is 2008-09.
What interventions are being tested in trial NCT00781534?
The interventions under investigation include: Ginseng (DRUG), ginsenoside RE (DRUG), Placebo (sugar pill) (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00781534?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.